Aurelien Birer

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Carbapenemase-producing Klebsiella oxytoca complex in France (2017-2023): Molecular epidemiology integrated with virulence and biofilm phenotypes.

Carbapenemase-producing Klebsiella oxytoca complex in France (2017-2023): Molecular epidemiology integrated with virulence and biofilm phenotypes.

Journal: Emerging microbes & infections
Published: August 03, 2026

Dietary emulsifiers and host inflammation synergistically drive genomic evolution of Crohn's disease-associated Escherichia coli toward enhanced pathogenicity.

Dietary emulsifiers and host inflammation synergistically drive genomic evolution of Crohn's disease-associated Escherichia coli toward enhanced pathogenicity.

Journal: Journal of Crohn's & colitis
Published: July 08, 2026

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".

Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".

Journal: Antimicrobial agents and chemotherapy
Published: June 24, 2026

Spread of carbapenemase-producing Serratia spp. in France from 2016 to 2024: a comparative genomic study.

Spread of carbapenemase-producing Serratia spp. in France from 2016 to 2024: a comparative genomic study.

Journal: Emerging microbes & infections
Published: May 07, 2026

Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.

Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France.

Journal: The Journal of antimicrobial chemotherapy
Published: February 20, 2026

In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.

In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.

Journal: Antimicrobial agents and chemotherapy
Published: February 12, 2026

Emergence and Polyclonal Dissemination of blaNDM-7-Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021-2023.

Emergence and Polyclonal Dissemination of blaNDM-7-Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021-2023.

Journal: Emerging infectious diseases
Published: September 29, 2025

Vat-Mediated Mucus Penetration Enables Genotoxic Activity of pks+ Escherichia coli.

Vat-Mediated Mucus Penetration Enables Genotoxic Activity of pks+ Escherichia coli.

Journal: International journal of molecular sciences
Published: April 26, 2025

Characterization of Carbapenemase-producing Enterobacterales isolated from patients returning from Sub-Saharan Africa, France, 2015-2022.

Characterization of Carbapenemase-producing Enterobacterales isolated from patients returning from Sub-Saharan Africa, France, 2015-2022.

Journal: The Journal of antimicrobial chemotherapy
Published: March 26, 2025

ChiA: a major player in the virulence of Crohn's disease-associated adherent and invasive Escherichia coli (AIEC).

ChiA: a major player in the virulence of Crohn's disease-associated adherent and invasive Escherichia coli (AIEC).

Journal: Gut microbes
Published: October 14, 2024

Oxacillinase-484-Producing Enterobacterales, France, 2018-2023.

Oxacillinase-484-Producing Enterobacterales, France, 2018-2023.

Journal: Emerging infectious diseases
Published: September 25, 2024

IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022.

IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022.

Journal: Emerging infectious diseases
Published: May 23, 2024
Showing 1-12 of 24

Last Updated: 09/26/2026